Anti-atherosclerotic potential of dihydropyridine calcium channel blockers.
作者： Norio Ishii , Takeshi Matsumura , Seiya Shimoda , Eiichi Araki
DOI: 10.5551/JAT.12450
关键词:
摘要: … model animals have revealed that dihydropyridine CCBs … Dihydropyridine CCBs can suppress ROS generation and … reports have revealed that dihydropyridine CCBs suppress the …
sci-hub.se 参考文章(123)
Spiros Vlahopoulos, Istvan Boldogh, Antonella Casola, Allan R. Brasier, Nuclear factor-κB-dependent induction of interleukin-8 gene expression by tumor necrosis factor α : Evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation Blood. ,vol. 94, pp. 1878- 1889 ,(1999) , 10.1182/BLOOD.V94.6.1878
Franklin H. Epstein, Valentin Fuster, Lina Badimon, Juan J. Badimon, James H. Chesebro, Coronary Artery Disease: Pathogenesis and Acute Coronary Syndromes Mount Sinai Journal of Medicine. ,vol. 68, pp. 167- 181 ,(2001) , 10.1056/NEJM199201303260506
Nikolaus Marx, Galina Sukhova, Curran Murphy, Peter Libby, Jorge Plutzky, Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro American Journal of Pathology. ,vol. 153, pp. 17- 23 ,(1998) , 10.1016/S0002-9440(10)65540-X
Mercedes Ricote, Andrew C. Li, Timothy M. Willson, Carolyn J. Kelly, Christopher K. Glass, The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature. ,vol. 391, pp. 79- 82 ,(1998) , 10.1038/34178
Patrizia Cristofori, Federica Crivellente, Mario Campagnola, Anna Fratta Pasini, Ulisse Garbin, Anna Rigoni, Maria Tosetti, John Turton, Ivo Faustinelli, Luciano Cominacini, Reduced progression of atherosclerosis in apolipoprotein E‐deficient mice treated with lacidipine is associated with a decreased susceptibility of low‐density lipoprotein to oxidation International Journal of Experimental Pathology. ,vol. 85, pp. 105- 114 ,(2004) , 10.1111/J.0959-9673.2004.00375.X
Patrizia Cristofori, Anna Lanzoni, Mauro Quartaroli, Antonio M Pastorino, Carlo Zancanaro, Luciano Cominacini, Giovanni Gaviraghi, John Turton, None, The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse. Journal of Hypertension. ,vol. 18, pp. 1429- 1436 ,(2000) , 10.1097/00004872-200018100-00010
Rita Rachmani, Zohar Levi, Bat-Sheva Zadok, Mordchai Ravid, Losartan and lercanidipine attenuate low‐density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: A randomized, prospective crossover study Clinical Pharmacology & Therapeutics. ,vol. 72, pp. 302- 307 ,(2002) , 10.1067/MCP.2002.127110
Günay Yetik Anacak, Levent Üstünes, Ozlem Yilmaz Dilsiz, Adviye Ergul, Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure. Vascular Pharmacology. ,vol. 53, pp. 193- 199 ,(2010) , 10.1016/J.VPH.2010.08.003
Alan R. Collins, Woerner P. Meehan, Ulrich Kintscher, Simon Jackson, Shu Wakino, Grace Noh, Wulf Palinski, Willa A. Hsueh, Ronald E. Law, Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 21, pp. 365- 371 ,(2001) , 10.1161/01.ATV.21.3.365
C. Szabo, C. Thiemermann, J.R. Vane, Dihydropyridine Antagonists and Agonists of Calcium Channels Inhibit the Induction of Nitric Oxide Synthase by Endotoxin in Cultured Macrophages Biochemical and Biophysical Research Communications. ,vol. 196, pp. 825- 830 ,(1993) , 10.1006/BBRC.1993.2323